查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1812383

医药合约销售外包市场

Pharmaceutical Contract Sales Outsourcing Market
出版日期: | 出版商: Transparency Market Research | 英文 190 Pages | 商品交期: 2-10个工作天内

价格

医药合约销售外包市场-报告范围

TMR 关于全球医药合约销售外包市场的报告研究了过去和当前的成长趋势和机会，以获得 2025 年至 2035 年预测期内市场指标的宝贵见解。该报告提供了 2025 年至 2035 年期间全球医药合约销售外包市场的收入，以 2025 年为基准年，2035 年为预测年。该报告也提供了 2025 年至 2035 年全球医药合约销售外包市场的年复合成长率(CAGR %)。

本报告经过广泛的研究后编写。主要研究工作量较大，分析师访问了关键意见领袖、产业领袖和舆论领袖。次要研究则参考了主要厂商的产品资料、年度报告、新闻稿和相关文件，以了解两轮车导航显示器市场。

市场概况
2024年的市场价值 109亿美元
2035年的市场价值 248亿美元
复合年增长率 7.7%

本报告深入探讨了全球两轮车导航显示器市场的竞争格局。报告已确定全球医药合约销售外包市场的主要参与者，并根据其各项属性对每位参与者进行了分析。本报告涵盖了公司概况、财务状况、近期发展和 SWOT 分析等内容，涵盖了全球医药合约销售外包市场参与者的各项属性。

全球医药合约销售外包市场报告解答的关键问题：

  • 预测期内，所有地区的血液分离术销售额/收入为何？
  • 全球两轮车导航显示器市场有哪些机会？
  • 市场的主要驱动因素、限制因素、机会和威胁是什么？
  • 在预测期内，哪个区域市场将以最快的复合年增长率扩张？
  • 预计哪个领域将在 2035 年创造全球最高收入？
  • 预测期内，哪个细分市场预计以最高复合年增长率扩张？
  • 在全球市场中经营的不同公司的市场地位如何？

医药合约销售外包市场-研究目标和研究方法

这份关于全球医药合约销售外包市场的综合报告首先概述了研究范围和目标。报告详细阐述了本研究的目标、市场中的主要供应商和分销商，以及产品审批的监管情况。

为了方便阅读，本报告采用章节式编排，每个章节又细分为多个小节。报告包含详尽的图表，并适当穿插。各关键细分市场的实际值和预测值以图形方式呈现，视觉上引人入胜。此外，报告也便于读者比较过去和预测期末各关键细分市场的市占率。

本报告从产品、最终用户和地区角度分析了全球医药合约销售外包市场。该报告对每个标准下的关键细分市场进行了深入研究，并提供了2035年底每个细分市场的市场份额。这些宝贵的见解使市场利益相关者能够在全球两轮车导航显示器市场投资时做出明智的商业决策。

目录

第一章：前言

第二章：假设与研究方法

第三章：执行摘要：全球市场

第四章：市场概况

  • 介绍
  • 概述
  • 市场动态
  • 2020年至2035年全球医药合约销售外包市场分析与预测

第五章：关键见解

  • 主要地区/国家的医疗保健支出
  • 医药销售外包的优势
  • 波特五力分析
  • 大环境分析
  • 重要产业事件（合作伙伴关係、协作、产品审批、併购）

第六章：全球市场分析与预测：依服务类型

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年按服务类型分類的市场价值预测
    • 个人推广
      • 促销销售团队
        • 专业的销售团队
        • 联合销售团队
      • 大客户管理
      • 空缺管理
    • 非个人推销
      • 电话咨询
      • 互动式电子细节
      • 客户服务
      • 医学科学联络员
      • 病人参与服务
      • 其他的
    • 其他的
  • 各服务类型的市场吸引力

第七章：全球市场分析与预测：依治疗领域

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年按治疗领域分類的市场价值预测
    • 心血管疾病
    • 肿瘤疾病
    • 呼吸系统疾病
    • 代谢紊乱
    • 神经系统疾病
    • 骨科疾病
    • 传染病
    • 其他的
  • 各治疗领域的市场吸引力

第八章：全球市场分析与预测：按最终用户

  • 介绍与定义
  • 主要发现/进展
  • 2020 年至 2035 年终端用户市场价值预测
    • 製药公司
      • 新药开发商
      • 仿製药开发商
      • 疫苗开发商
    • 生技公司
  • 最终用户的市场吸引力

第九章：全球市场分析与预测：按地区

  • 主要发现
  • 各地区市场价值预测
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 各地区市场吸引力

第十章：北美市场分析与预测

  • 我们
  • 加拿大

第 11 章：欧洲市场分析与预测

  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 瑞士
  • 荷兰
  • 欧洲其他地区

第 12 章：亚太市场分析与预测

  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲和纽西兰
  • 亚太其他地区

第十三章：拉丁美洲市场分析与预测

  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区

第 14 章：中东和非洲市场分析与预测

  • 海湾合作委员会国家
  • 南非
  • 中东和非洲其他地区

第 15 章：竞争格局

  • 市场参与者 - 竞争矩阵（依公司层级和规模）
  • 各公司市占率分析（2024年）
  • 公司简介
    • IQVIA
    • Axxelus
    • EPS Corporation (EPS Holdings, Inc.)
    • Syneos Health
    • EVERSANA
    • CMIC HOLDINGS Co., LTD.
    • QFR Solutions
    • Sales Focus Inc.
    • GTS Solution
    • Mercalis
    • MaBiCo
    • Mednext Pharmaceuticals Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • Promoveo Health
    • Agilify Solutions Inc.
Product Code: TMRGL28562

Pharmaceutical Contract Sales Outsourcing Market- Scope of Report

TMR's report on the global Pharmaceutical Contract Sales Outsourcing Marketstudies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the Market during the forecast period from 2025 to 2035. The report provides revenue of the global Pharmaceutical Contract Sales Outsourcing Marketfor the period 2025 to 2035, considering 2025 as the base year and 2035 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global Pharmaceutical Contract Sales Outsourcing Marketfrom 2025 to 2035.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the Pharmaceutical Contract Sales Outsourcing Market .

Market Snapshot
Market Value in 2024US$ 10.9 Bn
Market Value in 2035US$ 24.8 Bn
CAGR7.7%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global Pharmaceutical Contract Sales Outsourcing Market .

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global Pharmaceutical Contract Sales Outsourcing Market . These serve as valuable tools for existing Market players as well as for entities interested in participating in the global Pharmaceutical Contract Sales Outsourcing Market .

The report delves into the competitive landscape of the global Pharmaceutical Contract Sales Outsourcing Market . Key players operating in the global Pharmaceutical Contract Sales Outsourcing Markethave been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global Pharmaceutical Contract Sales Outsourcing Marketprofiled in this report.

Key Questions Answered in Global Pharmaceutical Contract Sales Outsourcing MarketReport:

  • What are the opportunities in the global Pharmaceutical Contract Sales Outsourcing Market ?
  • What are the major drivers, restraints, opportunities, and threats in the Market ?
  • Which regional Market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2035?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the Market positions of different companies operating in the global Market ?

Pharmaceutical Contract Sales Outsourcing Market- Research Objectives and Research Approach

The comprehensive report on the global Pharmaceutical Contract Sales Outsourcing Marketbegins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the Market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the Market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global Pharmaceutical Contract Sales Outsourcing Marketin terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the Market share for each of these at the end of 2035 has been provided. Such valuable insights enable Market stakeholders in making informed business decisions for investment in the global Pharmaceutical Contract Sales Outsourcing Market .

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Pharmaceutical Contract Sales Outsourcing Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Segment Definition
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, 2020 to 2035
    • 4.4.1. Market Revenue Projections (US$ Bn)

5. Key Insights

  • 5.1. Healthcare Expenditure across Key Regions / Countries
  • 5.2. Advantages of Pharmaceutical Sales Outsourcing
  • 5.3. PORTER's Five Forces Analysis
  • 5.4. PESTLE Analysis
  • 5.5. Key Industry Events (Partnership, Collaborations, Product approvals, merger & acquisitions)

6. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By Service Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Market Value Forecast By Service Type, 2020 to 2035
    • 6.3.1. Personal Promotion
      • 6.3.1.1. Promotional Sales Team
        • 6.3.1.1.1. Dedicated Sales Team
        • 6.3.1.1.2. Syndicated Sales Team
      • 6.3.1.2. Key Account Management
      • 6.3.1.3. Vacancy Management
    • 6.3.2. Non-Personal Promotion
      • 6.3.2.1. Tele-detailing
      • 6.3.2.2. Interactive E-Detailing
      • 6.3.2.3. Customer Service
      • 6.3.2.4. Medical Science Liaisons
      • 6.3.2.5. Patient Engagement Services
      • 6.3.2.6. Others
    • 6.3.3. Others
  • 6.4. Market Attractiveness By Service Type

7. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By Therapeutic Area

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 7.3.1. Cardiovascular Disorders
    • 7.3.2. Oncological Disorders
    • 7.3.3. Respiratory Disorders
    • 7.3.4. Metabolic Disorders
    • 7.3.5. Neurological Disorders
    • 7.3.6. Orthopedic Disorders
    • 7.3.7. Infectious Diseases
    • 7.3.8. Others
  • 7.4. Market Attractiveness By Therapeutic Area

8. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By End-user

  • 8.1. Introduction & Definition
  • 8.2. Key Findings / Developments
  • 8.3. Market Value Forecast By End-user, 2020 to 2035
    • 8.3.1. Pharmaceutical Companies
      • 8.3.1.1. Novel Drug Developers
      • 8.3.1.2. Generic Drug Developers
      • 8.3.1.3. Vaccine Developers
    • 8.3.2. Biotechnology Companies
  • 8.4. Market Attractiveness By End-user

9. Global Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecasts, By Region

  • 9.1. Key Findings
  • 9.2. Market Value Forecast By Region
    • 9.2.1. North America
    • 9.2.2. Europe
    • 9.2.3. Asia Pacific
    • 9.2.4. Latin America
    • 9.2.5. Middle East & Africa
  • 9.3. Market Attractiveness By Region

10. North America Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
  • 10.2. Market Value Forecast By Service Type, 2020 to 2035
    • 10.2.1. Personal Promotion
      • 10.2.1.1. Promotional Sales Team
        • 10.2.1.1.1. Dedicated Sales Team
        • 10.2.1.1.2. Syndicated Sales Team
      • 10.2.1.2. Key Account Management
      • 10.2.1.3. Vacancy Management
    • 10.2.2. Non-Personal Promotion
      • 10.2.2.1. Tele-detailing
      • 10.2.2.2. Interactive E-Detailing
      • 10.2.2.3. Customer Service
      • 10.2.2.4. Medical Science Liaisons
      • 10.2.2.5. Patient Engagement Services
      • 10.2.2.6. Others
    • 10.2.3. Others
  • 10.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 10.3.1. Cardiovascular Disorders
    • 10.3.2. Oncological Disorders
    • 10.3.3. Respiratory Disorders
    • 10.3.4. Metabolic Disorders
    • 10.3.5. Neurological Disorders
    • 10.3.6. Orthopedic Disorders
    • 10.3.7. Infectious Diseases
    • 10.3.8. Others
  • 10.4. Market Value Forecast By End-user, 2020 to 2035
    • 10.4.1. Pharmaceutical Companies
      • 10.4.1.1. Novel Drug Developers
      • 10.4.1.2. Generic Drug Developers
      • 10.4.1.3. Vaccine Developers
    • 10.4.2. Biotechnology Companies
  • 10.5. Market Value Forecast By Country, 2020 to 2035
    • 10.5.1. U.S.
    • 10.5.2. Canada
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Service Type
    • 10.6.2. By Therapeutic Area
    • 10.6.3. By End-user
    • 10.6.4. By Country

11. Europe Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast By Service Type, 2020 to 2035
    • 11.2.1. Personal Promotion
      • 11.2.1.1. Promotional Sales Team
        • 11.2.1.1.1. Dedicated Sales Team
        • 11.2.1.1.2. Syndicated Sales Team
      • 11.2.1.2. Key Account Management
      • 11.2.1.3. Vacancy Management
    • 11.2.2. Non-Personal Promotion
      • 11.2.2.1. Tele-detailing
      • 11.2.2.2. Interactive E-Detailing
      • 11.2.2.3. Customer Service
      • 11.2.2.4. Medical Science Liaisons
      • 11.2.2.5. Patient Engagement Services
      • 11.2.2.6. Others
    • 11.2.3. Others
  • 11.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 11.3.1. Cardiovascular Disorders
    • 11.3.2. Oncological Disorders
    • 11.3.3. Respiratory Disorders
    • 11.3.4. Metabolic Disorders
    • 11.3.5. Neurological Disorders
    • 11.3.6. Orthopedic Disorders
    • 11.3.7. Infectious Diseases
    • 11.3.8. Others
  • 11.4. Market Value Forecast By End-user, 2020 to 2035
    • 11.4.1. Pharmaceutical Companies
      • 11.4.1.1. Novel Drug Developers
      • 11.4.1.2. Generic Drug Developers
      • 11.4.1.3. Vaccine Developers
    • 11.4.2. Biotechnology Companies
  • 11.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 11.5.1. Germany
    • 11.5.2. U.K.
    • 11.5.3. France
    • 11.5.4. Italy
    • 11.5.5. Spain
    • 11.5.6. Switzerland
    • 11.5.7. The Netherlands
    • 11.5.8. Rest of Europe
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Service Type
    • 11.6.2. By Therapeutic Area
    • 11.6.3. By End-user
    • 11.6.4. By Country / Sub-region

12. Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast By Service Type, 2020 to 2035
    • 12.2.1. Personal Promotion
      • 12.2.1.1. Promotional Sales Team
        • 12.2.1.1.1. Dedicated Sales Team
        • 12.2.1.1.2. Syndicated Sales Team
      • 12.2.1.2. Key Account Management
      • 12.2.1.3. Vacancy Management
    • 12.2.2. Non-Personal Promotion
      • 12.2.2.1. Tele-detailing
      • 12.2.2.2. Interactive E-Detailing
      • 12.2.2.3. Customer Service
      • 12.2.2.4. Medical Science Liaisons
      • 12.2.2.5. Patient Engagement Services
      • 12.2.2.6. Others
    • 12.2.3. Others
  • 12.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 12.3.1. Cardiovascular Disorders
    • 12.3.2. Oncological Disorders
    • 12.3.3. Respiratory Disorders
    • 12.3.4. Metabolic Disorders
    • 12.3.5. Neurological Disorders
    • 12.3.6. Orthopedic Disorders
    • 12.3.7. Infectious Diseases
    • 12.3.8. Others
  • 12.4. Market Value Forecast By End-user, 2020 to 2035
    • 12.4.1. Pharmaceutical Companies
      • 12.4.1.1. Novel Drug Developers
      • 12.4.1.2. Generic Drug Developers
      • 12.4.1.3. Vaccine Developers
    • 12.4.2. Biotechnology Companies
  • 12.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 12.5.1. China
    • 12.5.2. India
    • 12.5.3. Japan
    • 12.5.4. South Korea
    • 12.5.5. Australia & New Zealand
    • 12.5.6. Rest of Asia Pacific
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Service Type
    • 12.6.2. By Therapeutic Area
    • 12.6.3. By End-user
    • 12.6.4. By Country / Sub-region

13. Latin America Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast By Service Type, 2020 to 2035
    • 13.2.1. Personal Promotion
      • 13.2.1.1. Promotional Sales Team
        • 13.2.1.1.1. Dedicated Sales Team
        • 13.2.1.1.2. Syndicated Sales Team
      • 13.2.1.2. Key Account Management
      • 13.2.1.3. Vacancy Management
    • 13.2.2. Non-Personal Promotion
      • 13.2.2.1. Tele-detailing
      • 13.2.2.2. Interactive E-Detailing
      • 13.2.2.3. Customer Service
      • 13.2.2.4. Medical Science Liaisons
      • 13.2.2.5. Patient Engagement Services
      • 13.2.2.6. Others
    • 13.2.3. Others
  • 13.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 13.3.1. Cardiovascular Disorders
    • 13.3.2. Oncological Disorders
    • 13.3.3. Respiratory Disorders
    • 13.3.4. Metabolic Disorders
    • 13.3.5. Neurological Disorders
    • 13.3.6. Orthopedic Disorders
    • 13.3.7. Infectious Diseases
    • 13.3.8. Others
  • 13.4. Market Value Forecast By End-user, 2020 to 2035
    • 13.4.1. Pharmaceutical Companies
      • 13.4.1.1. Novel Drug Developers
      • 13.4.1.2. Generic Drug Developers
      • 13.4.1.3. Vaccine Developers
    • 13.4.2. Biotechnology Companies
  • 13.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 13.5.1. Brazil
    • 13.5.2. Mexico
    • 13.5.3. Argentina
    • 13.5.4. Rest of Latin America
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Service Type
    • 13.6.2. By Therapeutic Area
    • 13.6.3. By End-user
    • 13.6.4. By Country / Sub-region

14. Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast By Service Type, 2020 to 2035
    • 14.2.1. Personal Promotion
      • 14.2.1.1. Promotional Sales Team
        • 14.2.1.1.1. Dedicated Sales Team
        • 14.2.1.1.2. Syndicated Sales Team
      • 14.2.1.2. Key Account Management
      • 14.2.1.3. Vacancy Management
    • 14.2.2. Non-Personal Promotion
      • 14.2.2.1. Tele-detailing
      • 14.2.2.2. Interactive E-Detailing
      • 14.2.2.3. Customer Service
      • 14.2.2.4. Medical Science Liaisons
      • 14.2.2.5. Patient Engagement Services
      • 14.2.2.6. Others
    • 14.2.3. Others
  • 14.3. Market Value Forecast By Therapeutic Area, 2020 to 2035
    • 14.3.1. Cardiovascular Disorders
    • 14.3.2. Oncological Disorders
    • 14.3.3. Respiratory Disorders
    • 14.3.4. Metabolic Disorders
    • 14.3.5. Neurological Disorders
    • 14.3.6. Orthopedic Disorders
    • 14.3.7. Infectious Diseases
    • 14.3.8. Others
  • 14.4. Market Value Forecast By End-user, 2020 to 2035
    • 14.4.1. Pharmaceutical Companies
      • 14.4.1.1. Novel Drug Developers
      • 14.4.1.2. Generic Drug Developers
      • 14.4.1.3. Vaccine Developers
    • 14.4.2. Biotechnology Companies
  • 14.5. Market Value Forecast By Country / Sub-region, 2020 to 2035
    • 14.5.1. GCC Countries
    • 14.5.2. South Africa
    • 14.5.3. Rest of Middle East & Africa
  • 14.6. Market Attractiveness Analysis
    • 14.6.1. By Service Type
    • 14.6.2. By Therapeutic Area
    • 14.6.3. By End-user
    • 14.6.4. By Country / Sub-region

15. Competition Landscape

  • 15.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 15.2. Market Share Analysis By Company (2024)
  • 15.3. Company Profiles
    • 15.3.1. IQVIA
      • 15.3.1.1. Company Overview
      • 15.3.1.2. Financial Overview
      • 15.3.1.3. Product Portfolio
      • 15.3.1.4. Business Strategies
      • 15.3.1.5. Recent Developments
    • 15.3.2. Axxelus
      • 15.3.2.1. Company Overview
      • 15.3.2.2. Financial Overview
      • 15.3.2.3. Product Portfolio
      • 15.3.2.4. Business Strategies
      • 15.3.2.5. Recent Developments
    • 15.3.3. EPS Corporation (EPS Holdings, Inc.)
      • 15.3.3.1. Company Overview
      • 15.3.3.2. Financial Overview
      • 15.3.3.3. Product Portfolio
      • 15.3.3.4. Business Strategies
      • 15.3.3.5. Recent Developments
    • 15.3.4. Syneos Health
      • 15.3.4.1. Company Overview
      • 15.3.4.2. Financial Overview
      • 15.3.4.3. Product Portfolio
      • 15.3.4.4. Business Strategies
      • 15.3.4.5. Recent Developments
    • 15.3.5. EVERSANA
      • 15.3.5.1. Company Overview
      • 15.3.5.2. Financial Overview
      • 15.3.5.3. Product Portfolio
      • 15.3.5.4. Business Strategies
      • 15.3.5.5. Recent Developments
    • 15.3.6. CMIC HOLDINGS Co., LTD.
      • 15.3.6.1. Company Overview
      • 15.3.6.2. Financial Overview
      • 15.3.6.3. Product Portfolio
      • 15.3.6.4. Business Strategies
      • 15.3.6.5. Recent Developments
    • 15.3.7. QFR Solutions
      • 15.3.7.1. Company Overview
      • 15.3.7.2. Financial Overview
      • 15.3.7.3. Product Portfolio
      • 15.3.7.4. Business Strategies
      • 15.3.7.5. Recent Developments
    • 15.3.8. Sales Focus Inc.
      • 15.3.8.1. Company Overview
      • 15.3.8.2. Financial Overview
      • 15.3.8.3. Product Portfolio
      • 15.3.8.4. Business Strategies
      • 15.3.8.5. Recent Developments
    • 15.3.9. GTS Solution
      • 15.3.9.1. Company Overview
      • 15.3.9.2. Financial Overview
      • 15.3.9.3. Product Portfolio
      • 15.3.9.4. Business Strategies
      • 15.3.9.5. Recent Developments
    • 15.3.10. Mercalis
      • 15.3.10.1. Company Overview
      • 15.3.10.2. Financial Overview
      • 15.3.10.3. Product Portfolio
      • 15.3.10.4. Business Strategies
      • 15.3.10.5. Recent Developments
    • 15.3.11. MaBiCo
      • 15.3.11.1. Company Overview
      • 15.3.11.2. Financial Overview
      • 15.3.11.3. Product Portfolio
      • 15.3.11.4. Business Strategies
      • 15.3.11.5. Recent Developments
    • 15.3.12. Mednext Pharmaceuticals Pvt. Ltd.
      • 15.3.12.1. Company Overview
      • 15.3.12.2. Financial Overview
      • 15.3.12.3. Product Portfolio
      • 15.3.12.4. Business Strategies
      • 15.3.12.5. Recent Developments
    • 15.3.13. Peak Pharma Solutions Inc.
      • 15.3.13.1. Company Overview
      • 15.3.13.2. Financial Overview
      • 15.3.13.3. Product Portfolio
      • 15.3.13.4. Business Strategies
      • 15.3.13.5. Recent Developments
    • 15.3.14. Promoveo Health
      • 15.3.14.1. Company Overview
      • 15.3.14.2. Financial Overview
      • 15.3.14.3. Product Portfolio
      • 15.3.14.4. Business Strategies
      • 15.3.14.5. Recent Developments
    • 15.3.15. Agilify Solutions Inc.
      • 15.3.15.1. Company Overview
      • 15.3.15.2. Financial Overview
      • 15.3.15.3. Product Portfolio
      • 15.3.15.4. Business Strategies
      • 15.3.15.5. Recent Developments

List of Tables

  • Table 01: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 02: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 03: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 04: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 05: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 06: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 07: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 08: Global Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Region, 2020 to 2035
  • Table 09: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country, 2020 to 2035
  • Table 10: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 11: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 12: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 13: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 14: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 15: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 16: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 17: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country/Sub-region, 2020 to 2035
  • Table 18: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 19: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 20: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 21: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 22: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 23: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 24: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 25: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 26: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 27: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 28: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 29: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 30: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 31: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 32: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 33: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 34: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 35: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 36: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 37: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 38: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 39: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 40: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035
  • Table 41: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, by Country / Sub-region, 2020 to 2035
  • Table 42: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Service Type, 2020 to 2035
  • Table 43: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Personal Promotion, 2020 to 2035
  • Table 44: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Promotional Sales Team, 2020 to 2035
  • Table 45: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Non-Personal Promotion, 2020 to 2035
  • Table 46: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Therapeutic Area, 2020 to 2035
  • Table 47: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By End-user, 2020 to 2035
  • Table 48: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, By Pharmaceutical Companies, 2020 to 2035

List of Figures

  • Figure 01: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 02: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 03: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Personal Promotion, 2020 to 2035
  • Figure 04: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Non-Personal Promotion, 2020 to 2035
  • Figure 05: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 06: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 07: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 08: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Cardiovascular Disorders, 2020 to 2035
  • Figure 09: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Oncological Disorders, 2020 to 2035
  • Figure 10: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Respiratory Disorders, 2020 to 2035
  • Figure 11: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Metabolic Disorders, 2020 to 2035
  • Figure 12: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Neurological Disorders, 2020 to 2035
  • Figure 13: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Orthopedic Disorders, 2020 to 2035
  • Figure 14: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Infectious Diseases, 2020 to 2035
  • Figure 15: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Others, 2020 to 2035
  • Figure 16: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 17: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 18: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Pharmaceutical Companies, 2020 to 2035
  • Figure 19: Global Pharmaceutical Contract Sales Outsourcing Market Revenue (US$ Bn), by Biotechnology Companies, 2020 to 2035
  • Figure 20: Global Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Region, 2024 and 2035
  • Figure 21: Global Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Region, 2025 to 2035
  • Figure 22: North America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 23: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country, 2024 and 2035
  • Figure 24: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country, 2025 to 2035
  • Figure 25: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 26: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 27: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 28: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 29: North America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 30: North America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 31: Europe Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 32: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 33: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 34: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 35: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 36: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 37: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 38: Europe Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 39: Europe Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 40: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 41: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country/Sub-region, 2024 and 2035
  • Figure 42: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country/Sub-region, 2025 to 2035
  • Figure 43: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 44: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 45: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 46: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 47: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 48: Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 49: Latin America Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 50: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 51: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 52: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 53: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 54: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 55: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 56: Latin America Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 57: Latin America Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035
  • Figure 58: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value (US$ Bn) Forecast, 2020 to 2035
  • Figure 59: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, by Country / Sub-region, 2024 and 2035
  • Figure 60: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, by Country / Sub-region, 2025 to 2035
  • Figure 61: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Service Type, 2024 and 2035
  • Figure 62: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Service Type, 2025 to 2035
  • Figure 63: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By Therapeutic Area, 2024 and 2035
  • Figure 64: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By Therapeutic Area, 2025 to 2035
  • Figure 65: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Value Share Analysis, By End-user, 2024 and 2035
  • Figure 66: Middle East & Africa Pharmaceutical Contract Sales Outsourcing Market Attractiveness Analysis, By End-user, 2025 to 2035